MANKIND
Invest Now

Mankind Pharma Share Price
₹2,372.15 -42.9 (-1.78%)
24 Mar, 2025 17:55
Start SIP in
MANKIND
Performance
- Low
- ₹2,328
- High
- ₹2,424
- 52 Week Low
- ₹1,901
- 52 Week High
- ₹3,055
- Open Price₹2,424
- Previous Close₹2,415
- Volume599,027
Investment Returns
- Over 1 Month + 1.91%
- Over 3 Month -20.89%
- Over 6 Month -10.49%
- Over 1 Year + 7.15%
Smart Investing Starts Here Start SIP with Mankind Pharma for Steady Growth!
Mankind Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 47.9
- PEG Ratio
- 2.7
- Market Cap Cr
- 97,870
- P/B Ratio
- 9.3
- Average True Range
- 93.89
- EPS
- 49.48
- Dividend Yield
- 0
- MACD Signal
- -64.12
- RSI
- 54.37
- MFI
- 68.92
Mankind Pharma Financials
Mankind Pharma Technicals
EMA & SMA
Current Price
₹2,372.15
-42.9
(-1.78%)

-
- Bearish Moving Average 7
-
- Bullish Moving Average 9
- 20 Day
- ₹2,291.16
- 50 Day
- ₹2,395.13
- 100 Day
- ₹2,461.63
- 200 Day
- ₹2,418.06
Resistance and Support
2374.57
- R3 2,516.68
- R2 2,470.12
- R1 2,421.13
- S1 2,325.58
- S2 2,279.02
- S3 2,230.03
Mankind Pharma Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-23 | Quarterly Results | |
2024-11-05 | Quarterly Results | |
2024-07-31 | Quarterly Results | |
2024-05-15 | Audited Results & Others | To evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. |
2024-01-31 | Quarterly Results |
Mankind Pharma F&O
About Mankind Pharma
- NSE Symbol
- MANKIND
- BSE Symbol
- 543904
- ISIN
- INE634S01028
Similar Stocks to Mankind Pharma
Mankind Pharma FAQs
Mankind Pharma share price is ₹2,372 As on 24 March, 2025 | 17:41
The Market Cap of Mankind Pharma is ₹97869.8 Cr As on 24 March, 2025 | 17:41
The P/E ratio of Mankind Pharma is 47.9 As on 24 March, 2025 | 17:41
The PB ratio of Mankind Pharma is 9.3 As on 24 March, 2025 | 17:41
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.